Wes is an English-qualified lawyer specialising in complex cross-border commercial disputes. He has deep experience across the full range of dispute resolution mechanisms and has a particular focus on clients operating in the IT and life sciences sectors. He regularly advises clients on pre-litigation strategy and has handled large-scale commercial litigation before the High Court and the Court of Appeal in the UK as well as in arbitrations under various institutional rules.

Wes trained and practised at a magic circle firm and at a leading US firm before joining Bristows in 2017. Wes speaks English, German and Welsh.

Wes’ recent representative experience includes:

• Acting for a biotech business in the defence of entitlement claims before the Patents Court concerning its core DNA manufacturing technology.
• Acting for a global aerospace business in connection with claims for breach of a call option agreement and breaches of an exclusivity arrangement for the supply of complex parts. Successful in recovering ca. $120m following a four-week trial in the Commercial Court.
• Defending a Japanese pharmaceutical company in an ad hoc arbitration seated in London in connection with the development and subsequent commercialisation of a blockbuster monoclonal antibody therapeutic.
• Acting for a major global electronics manufacturer in an ICC arbitration seated in London in connection with alleged breaches of a licensing agreement for the supply of chips.
• Acting for the world’s largest advertising group in defence of a claim concerning the meaning and effect of an earn-out provision in a sale and purchase agreement for complex software responsible for administering programmatic advertising campaigns. Trial in the Commercial Court.
• Advising an aerospace manufacturer in connection with a series of disputes with airlines over the supply of complex parts.
• Advising a global technology brand providing specialised mining systems and equipment in dispute with a supplier over alleged breaches of contract and intellectual property infringement.
• Acting for a life sciences business in dispute with its CRO over the running of Phase II clinical trials.
• Acting for an IT services provider against HM Government in connection with historic claims of overcharging under a long-term IT services contract.
• Acting for an IT services provider faced with complaints of producing allegedly faulty code during the implementation of a complex IT system.
• Advising an app developer in connection with claims for indemnification arising out of alleged breaches of third-party intellectual property rights.
• Advising an IT services provider in connection with quality complaints arising out of the development of a bespoke IT system.
• Advising individuals in connection with the settlement of claims arising out of the London Capital & Finance minibonds scandal.
• Defending a South African sales and merchandising company in an arbitration concerning the meaning and effect of various commercial contracts.